We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Caspase-8 Initiates T-Cell Activation

By Biotechdaily staff writers
Posted on 16 Apr 2003
A new study has shown that the enzyme caspase-8, known to be a critical factor in the process of apoptosis or programmed cell death, is directly involved in controlling immune system response through initiation of T-cell activation. More...
The study was published March 21, 2003, in the online edition of Genes & Development.

The current study was based on earlier findings that had linked caspase-8 mutations to immunodeficiency in humans. To learn more about caspase-8, investigators from the University of Toronto (Canada; www.utoronto.ca) genetically engineered a line of mice that produced T-cells lacking the gene for caspase-8. This type of model was necessary, as mice completely lacking caspase-8 died as embryos.

The mutant mice showed a marked decrease in the number of peripheral T-cells. These cells grown in culture showed an impaired response to activation stimuli. Moreover, caspase-8 mutant mice were unable to mount an immune response to viral infection, indicating that caspase-8 deletion in T-cells led to immunodeficiency.

"This research has helped us better understand how caspase-8 activates the immune system response by triggering T-cells to proliferate. When caspase-8 is inhibited, the immune response is significantly decreased,” explained senior author Dr. Razqallah Hakem, assistant professor in medical biophysics at the University of Toronto.



Related Links:
University of Toronto

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Steam Sterilizer
Hi Vac II Line
New
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.